BeStock  

Tenet Healthcare THC

US equityMarket cap rank #876Medical Care Facilities
$263.19 −$0.40 (-0.15%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $263.19 0.00%
Open$265.14
Prev close$263.59
Day range$261.15 – $266.62
Volume705.0K
Market cap$20.95B
P/E (TTM)7.7
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$6.28B+18.7% YoY
Operating profit$1.72B+110.5% YoY
Net profit$1.22B+110.5% YoY
Diluted EPS$12.41+221.5% YoY
Free cash flow$1.08B+39.2% YoY
Operating cash flow$1.28B

Revenue, last 8 quarters

$5.1BDec '24$5.2BMar '25$5.3BJun '25$5.3BSep '25$5.5BDec '25$5.8BMar '26$6.0BJun '26$6.3BSep '26

Net profit, last 8 quarters

$572.0MDec '24$622.0MMar '25$522.0MJun '25$579.0MSep '25$644.0MDec '25$906.0MMar '26$1.0BJun '26$1.2BSep '26

Diluted EPS by quarter

3.32Dec '244.27Mar '253.14Jun '253.86Sep '254.22Dec '258.01Mar '269.84Jun '2612.41Sep '26

Free cash flow by quarter

$-661.0MDec '24$642.0MMar '25$743.0MJun '25$778.0MSep '25$367.0MDec '25$1.5BMar '26$417.0MJun '26$1.1BSep '26

Annual revenue

$17.6BFY20$19.5BFY21$19.2BFY22$20.6BFY23$20.7BFY24$21.3BFY25

Profitability & balance sheet

Gross margin83.3%
Operating margin22.5%
Net margin12.3%
Return on equity61.3%
Return on assets9.5%
Return on invested capital19.8%
Current ratio1.58
Liabilities / assets69.6%
Cash & investments$2.67B
Total debt$13.24B
Net cash (debt)-$10.57B
Free cash flow / sales14.1%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Hospital operations$4.26B 67.9%
  • Ambulatory Care$1.37B 21.8%
  • Revenue from contract termination$646.00M 10.3%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Operating Revenue $6.28B $6.04B $5.78B $21.31B $5.53B
Cost of Revenue $983.00M $984.00M $961.00M $3.78B $1.01B
Gross Profit $5.29B $5.06B $4.82B $17.53B $4.52B
Operating Expense $3.57B $3.62B $3.53B $14.09B $3.65B
Selling and Admin Expenses $2.17B $2.23B $2.17B $8.71B $2.22B
-General & Admin Expense $2.17B $2.23B $2.17B $8.71B $2.22B
Depreciation & Amortization & Depletion $217.00M $215.00M $229.00M $863.00M $231.00M
-Depreciation & Amortization $217.00M $215.00M $229.00M $863.00M $231.00M
Other Operating Expenses $1.18B $1.17B $1.12B $4.52B $1.20B
Operating Profit $1.72B $1.44B $1.30B $3.44B $869.00M
Net Non-Operating Interest Income (Expense) -$203.00M -$204.00M -$205.00M -$821.00M -$205.00M
Non-Operating Interest Expense $203.00M $204.00M $205.00M $821.00M $205.00M
Other Income (Expense) $62.00M $107.00M $42.00M $182.00M $17.00M
Earnings from Equity Interest $64.00M $65.00M $51.00M $264.00M $83.00M
Special Income (Charges) -$39.00M -$1.00M -$50.00M -$199.00M -$103.00M
-Less:Other Special Charges $11.00M $3.00M $27.00M $83.00M $49.00M
-Less:Write Off $37.00M $31.00M $7.00M – –
-Gain on Sale Of Business $9.00M $33.00M $1.00M -$1.00M -$5.00M
Other Non-Operating Income (Expenses) $37.00M $43.00M $41.00M $117.00M $37.00M
Pretax Profit $1.58B $1.34B $1.13B $2.80B $681.00M
Tax $360.00M $295.00M $226.00M $433.00M $37.00M
Net Profit $1.22B $1.05B $906.00M $2.37B $644.00M
Profit from Continuing Operations $1.22B $1.05B $906.00M $2.37B $644.00M
Minority Interests $219.00M $219.00M $204.00M $960.00M $273.00M
Net Income to Parent Company $1.00B $826.00M $702.00M $1.41B $371.00M
Net Income to Common Stockholders $1.00B $826.00M $702.00M $1.41B $371.00M
Basic EPS $12.48 $9.89 $8.09 $15.61 $4.25
Diluted EPS $12.41 $9.84 $8.01 $15.49 $4.22
Dividend Per Share $0.00 $0.00 $0.00 $0.00 $0.00
-Less:Restructuring and Mergern & Acquisition – – $17.00M $54.00M $1.00M
Total Revenue as Reported – – – $21.31B $5.53B
-Less:Impairment of Capital Assets – – – $61.00M –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $31.59B $30.68B $31.20B $29.68B $29.68B
Total Current Assets $8.43B $7.83B $8.36B $7.85B $7.85B
Cash and Cash Equivalents & Short-Term Investments $2.67B $2.17B $2.97B $2.88B $2.88B
-Cash and Cash Equivalents $2.67B $2.17B $2.97B $2.88B $2.88B
Receivables $4.55B $4.62B $4.36B $3.86B $3.86B
-Accounts Receivable $2.60B $2.61B $2.61B $2.57B $2.57B
-Notes Receivable $434.00M $414.00M $395.00M – –
-Other Receivables $1.52B $1.60B $1.36B $1.29B $1.29B
Prepaid Assets $360.00M $338.00M $351.00M $423.00M $423.00M
Inventory $340.00M $338.00M $343.00M $348.00M $348.00M
Other Current Assets $443.00M $300.00M $271.00M $278.00M $278.00M
Total Non-Current Assets $23.16B $22.85B $22.85B $21.83B $21.83B
Net PPE $6.29B $6.26B $6.25B $7.45B $7.45B
-Gross PPE $13.35B $13.18B $13.07B $14.13B $14.13B
-Accumulated Depreciation -$7.06B -$6.92B -$6.81B -$6.68B -$6.68B
Goodwill and Other Intangible Assets $12.87B $12.72B $12.70B $12.55B $12.55B
-Goodwill $11.64B $11.44B $11.39B $11.20B $11.20B
-Other Intangible Assets $1.23B $1.28B $1.32B $1.35B $1.35B
Non-Current Deferred Assets $49.00M $71.00M $84.00M $84.00M $84.00M
Other Non-Current Assets $3.96B $3.80B $3.81B $54.00M $54.00M
Total Liabilities $22.00B $21.98B $22.35B $20.70B $20.70B
Total Current Liabilities $5.32B $5.57B $6.15B $4.46B $4.46B
Payables $1.41B $1.44B $1.58B $1.36B $1.36B
-Accounts Payable $1.39B $1.37B $1.34B $1.36B $1.36B
-Total Tax Payable $22.00M $69.00M $236.00M $0.00 $0.00
Current Accrued Expenses $213.00M $113.00M $256.00M $81.00M $81.00M
Short-Term Debt and Capital Lease Obligation $164.00M $160.00M $81.00M $79.00M $79.00M
-Current Debt $164.00M $160.00M $81.00M $79.00M $79.00M
Current Provisions $317.00M $292.00M $303.00M $276.00M $276.00M
Other Current Liabilities $2.34B $2.70B $3.08B $1.81B $1.81B
Total Non-Current Liabilities $16.68B $16.41B $16.20B $16.24B $16.24B
Long Term Debt and Capital Lease Obligation $13.08B $13.09B $13.13B $13.09B $13.09B
-Long Term Debt $13.08B $13.09B $13.13B $13.09B $13.09B
Non-Current Liabilities $979.00M $978.00M $938.00M $951.00M $951.00M
Non-Current Deferred Liabilities $529.00M $325.00M $199.00M $240.00M $240.00M
Employee Benefits $238.00M $241.00M $243.00M $245.00M $245.00M
Other Non-Current Liabilities $1.86B $1.78B $1.69B $1.71B $1.71B
Total Equity $9.59B $8.70B $8.85B $8.97B $8.97B
Stockholders' Equity $5.44B $4.66B $4.81B $4.22B $4.22B
Capital Stock $8.00M $8.00M $8.00M $8.00M $8.00M
-Common Stock $8.00M $8.00M $8.00M $8.00M $8.00M
Additional Paid-In Capital $5.24B $5.19B $5.12B $4.91B $4.91B
Retained Earnings $6.94B $5.94B $5.12B $4.42B $4.42B
Less: Treasury Stock -$6.57B -$6.31B -$5.26B -$4.94B -$4.94B
Gains/Losses Not Affecting Retained Earnings -$178.00M -$177.00M -$179.00M -$181.00M -$181.00M
Minority Interests $4.15B $4.04B $4.04B $4.75B $4.75B
Investments and Advances – – – $1.44B $1.44B
-Available for Sale Securities – – – $59.00M $59.00M
-Long Term Equity Investment – – – $1.38B $1.38B
Non Current Accounts Receivables – – – $203.00M $203.00M
Non-Current Prepaid Assets – – – $50.00M $50.00M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $1.28B $585.00M $1.64B $3.54B $731.00M
Net cash flow from continuing operations $1.28B $585.00M $1.64B $3.54B $731.00M
Net Income from Continuing Operations $1.22B $1.05B $906.00M $2.37B $644.00M
Gain/Loss from Continuing Operations -$4.00M -$72.00M $27.00M -$33.00M -$16.00M
Depreciation & Depletion & Amortization $217.00M $215.00M $229.00M $863.00M $231.00M
Deferred Tax $227.00M $137.00M -$40.00M $9.00M -$42.00M
Other Non-Cash Items -$47.00M -$9.00M -$6.00M $29.00M $66.00M
Change in Working Capital -$441.00M -$785.00M $493.00M $140.00M -$172.00M
-Change in Receivables $22.00M -$5.00M -$28.00M $20.00M -$48.00M
-Change in Inventory -$38.00M -$158.00M $407.00M -$73.00M -$15.00M
-Change in Payables and Accrued Expense -$404.00M -$493.00M -$145.00M $209.00M -$28.00M
-Change in Other Current Liabilities $10.00M $36.00M $0.00 $9.00M -$41.00M
-Change In Other Working Capital -$31.00M -$165.00M $259.00M -$25.00M -$40.00M
Net cash flow from investing -$298.00M -$203.00M -$317.00M -$1.28B -$389.00M
Net Cash Flow from Continuing Investing Activities -$298.00M -$203.00M -$317.00M -$1.28B -$389.00M
Net PPE Purchase and Sale -$193.00M -$164.00M -$178.00M -$972.00M -$344.00M
Net Business Purchase and Sale -$71.00M -$9.00M -$121.00M -$308.00M -$42.00M
Net Investment Purchase and Sale -$30.00M -$22.00M -$4.00M $3.00M -$2.00M
Net Other Investing Changes -$4.00M -$8.00M -$14.00M $2.00M -$1.00M
Financing Cash Flow -$479.00M -$1.18B -$1.24B -$2.40B -$434.00M
Net Cash Flow from Continuing Financing Activities -$479.00M -$1.18B -$1.24B -$2.40B -$434.00M
Net Issuance Payments Of Debt -$15.00M -$12.00M -$19.00M -$96.00M -$27.00M
Net Common Stock Issuance -$255.00M -$1.04B -$318.00M -$1.39B -$198.00M
Net Other Financing Charges -$209.00M -$125.00M -$903.00M -$919.00M -$209.00M
Ending Cash Balance $2.67B $2.17B $2.97B $2.88B $2.88B
Net Change in Cash $504.00M -$797.00M $84.00M -$136.00M -$92.00M
Beginning Cash Balance $2.17B $2.97B $2.88B $3.02B $2.98B
Free Cash Flow $1.08B $417.00M $1.46B $2.53B $367.00M

Discussion

No comments yet — be the first to weigh in on THC.

Sign in to join the discussion.

Scroll to Top